Delivery of ketotifen fumarate by commercial contact lens materials

Optometry and Vision Science

Volumn 89, Issue 8, 2012, Pages 1140-1149

  Soluri, Anthony ^a   Hui, Alex ^a   Jones, Lyndon ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

contact lens; daily disposables; drug delivery; ketotifen fumarate

Indexed keywords

CHARGED SURFACES; CONTACT LENS MATERIAL; DELIVERY SYSTEMS; DISPOSABLES; EYE DROPS; FUMARATES; INITIAL TIME; KETOTIFEN; SILICONE HYDROGELS; ULTRAVIOLET ABSORBANCE;

CONTACT LENSES; DROPS; DRUG DELIVERY; HYDROGELS; SILICONES; THIOPHENE;

LOADING;

ANTIALLERGIC AGENT; EYE DROPS; KETOTIFEN;

ARTICLE; COMPARATIVE STUDY; CONTACT LENS; DRUG DELIVERY SYSTEM; HUMAN; SPECTROPHOTOMETRY;

ANTI-ALLERGIC AGENTS; CONTACT LENSES; DRUG DELIVERY SYSTEMS; HUMANS; KETOTIFEN; OPHTHALMIC SOLUTIONS; SPECTROPHOTOMETRY;

EID: 84864659056     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e3182639dc8     Document Type: Article

References (25)

1. Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am 2008;28:43-58.
2. Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population. Pediatr Allergy Immunol 2004;15:551-7.
3. Xu J, Li X, Sun F. In vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug delivery. Drug Deliv 2011;18:150-8.
4. Greiner JV, Mundorf T, Dubiner H, Lonsdale J, Casey R, Parver L, Kapik BM, Shams NB, Abelson MB. Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. Am J Ophthalmol 2003;136:1097-105.
5. Nabe M, Miyagawa H, Agrawal DK, Sugiyama H, Townley RG. The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis. Allergy Proc 1991;12:267-71.
6. Ali M, Horikawa S, Venkatesh S, Saha J, Hong JW, Byrne ME. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. J Control Release 2007;124:154-62.
7. Devillier P, Arnoux B, Lalau Keraly C, Landes A, Marsac J, Benveniste J. Inhibition of human and rabbit platelet activation by ketotifen. Fundam Clin Pharmacol 1990;4:1-9.
8. Kidd M, McKenzie SH, Steven I, Cooper C, Lanz R. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis. Br J Ophthalmol 2003;87:1206-11.
9. Avunduk AM, Tekelioglu Y, Turk A, Akyol N. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: A 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Clin Ther 2005;27:1392-402.
10. Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems-recent advances. Prog Retin Eye Res 1998;17:33-58.
11. Ciolino JB, Dohlman CH, Kohane DS. Contact lenses for drug delivery. Semin Ophthalmol 2009;24:156-60.
12. Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye (Lond) 1998;12(Pt 2):234-6.
13. Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol 2009;127:732-6.
14. Boone A, Hui A, Jones L. Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses. Eye Contact Lens 2009;35:260-7.
15. Urtti A, Salminen L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol 1993;37: 435-56.
16. Lederer CM, Jr., Harold RE. Drop size of commercial glaucoma medications. Am J Ophthalmol 1986;101:691-4.
17. Li CC, Chauhan A. Modeling ophthalmic drug delivery by soaked contact lenses. Ind Eng Chem Res 2006;45:3718-34.
18. Sedlacek J. [Possibility of the application of ophthalmic drugs with the use of gel contact lenses]. Cesk Oftalmol 1965;21:509-12.
19. Peppas N, Moynihan H. Structure and physical properties of poly(2- hydroxyethylmethacrylate) hydrogels. In: Peppas N, ed. Hydrogels in Medicine and Pharmacy, Vol. II: Polymers. Boca Raton, FL: CRC Press, Inc.; 1986:57-60.
20. Karlgard CC, Wong NS, Jones LW, Moresoli C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 2003;257: 141-51.
21. Guerrero S, Muniz E, Teijon C, Olmo R, Teijon JM, Blanco MD. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: Characterization and in vivo evaluation. J Pharm Sci 2008;97: 3153-69.
22. Morgan PB, Efron N. The oxygen performance of contemporary hydrogel contact lenses. Cont Lens Anterior Eye 1998;21:3-6.
23. Efron N, Young G, Brennan NA. Ocular surface temperature. Curr Eye Res 1989;8:901-6.
24. Lesher GA, Gunderson GG. Continuous drug delivery through the use of disposable contact lenses. Optom Vis Sci 1993;70: 1012-8.
25. Yanni JM, Stephens DJ, Parnell DW, Spellman JM. Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use. J Ocul Pharmacol 1994;10:665-75.